These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21098240)

  • 1. The antibiotic monensin causes cell cycle disruption of Toxoplasma gondii mediated through the DNA repair enzyme TgMSH-1.
    Lavine MD; Arrizabalaga G
    Antimicrob Agents Chemother; 2011 Feb; 55(2):745-55. PubMed ID: 21098240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii.
    Garrison EM; Arrizabalaga G
    Mol Microbiol; 2009 Apr; 72(2):425-41. PubMed ID: 19291232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of monensin sensitivity in Toxoplasma gondii reveals autophagy as a mechanism for drug induced death.
    Lavine MD; Arrizabalaga G
    PLoS One; 2012; 7(7):e42107. PubMed ID: 22848721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.
    Charvat RA; Arrizabalaga G
    Sci Rep; 2016 Mar; 6():22997. PubMed ID: 26976749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance towards monensin is proposed to be acquired in a Toxoplasma gondii model by reduced invasion and egress activities, in addition to increased intracellular replication.
    Thabet A; Schmidt J; Baumann S; Honscha W; VON Bergen M; Daugschies A; Bangoura B
    Parasitology; 2018 Mar; 145(3):313-325. PubMed ID: 28870270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice.
    Leesombun A; Nihei CI; Kondoh D; Nishikawa Y
    Parasitol Res; 2022 Jan; 121(1):413-422. PubMed ID: 34750652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of the polyether ionophorous antibiotic monensin against the cyst form of Toxoplasma gondii.
    Couzinet S; Dubremetz JF; Buzoni-Gatel D; Jeminet G; Prensier G
    Parasitology; 2000 Oct; 121 ( Pt 4)():359-65. PubMed ID: 11072898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional changes in Toxoplasma gondii in response to treatment with monensin.
    Zhai B; He JJ; Elsheikha HM; Li JX; Zhu XQ; Yang X
    Parasit Vectors; 2020 Feb; 13(1):84. PubMed ID: 32070423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Fis1 Interactors in Toxoplasma gondii Reveals a Novel Protein Required for Peripheral Distribution of the Mitochondrion.
    Jacobs K; Charvat R; Arrizabalaga G
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047127
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of Natural Polyether Ionophores: Monensin and Salinomycin against Clinical Staphylococcus epidermidis Strains.
    Stefańska J; Stępień K; Huczyński A; Tyski S
    Pol J Microbiol; 2015; 64(3):273-8. PubMed ID: 26638535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid method for determining salinomycin and monensin sensitivity in Eimeria tenella.
    Jenkins MC; O'Brien CN; Fuller L; Mathis GF; Fetterer R
    Vet Parasitol; 2014 Dec; 206(3-4):153-8. PubMed ID: 25312355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis.
    Szkudlarek-Mikho M; Saunders RA; Yap SF; Ngeow YF; Chin KV
    Biochem Biophys Res Commun; 2012 Nov; 428(4):487-93. PubMed ID: 23123626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of salinomycin and monensin on Streptococcus bovis strain ATCC 9809.
    Leblanc D; Morin A; Daigneault J
    Microbios; 1993; 76(306):41-5. PubMed ID: 8264432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedlot growth performance of steers on salinomycin, monensin and a daily rotation between the two.
    Casey NH; Wessels RH; Meissner HH
    J S Afr Vet Assoc; 1994 Dec; 65(4):160-3. PubMed ID: 7602568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
    Yoon MJ; Kang YJ; Kim IY; Kim EH; Lee JA; Lim JH; Kwon TK; Choi KS
    Carcinogenesis; 2013 Aug; 34(8):1918-28. PubMed ID: 23615398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the anticoccidial compound, lasalocid, against Toxoplasma gondii in cultured cells.
    Melton ML; Sheffield HG
    J Parasitol; 1975 Aug; 61(4):713-7. PubMed ID: 809567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of salinomycin and monensin derivatives against Trypanosoma brucei.
    Steverding D; Antoszczak M; Huczyński A
    Parasit Vectors; 2016 Jul; 9(1):409. PubMed ID: 27457761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monensin and salinomycin on amylase release from the superfused parotid segments of sheep and rat.
    Katoh K; Tsuda T
    Res Vet Sci; 1986 Sep; 41(2):207-10. PubMed ID: 2430321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic Potential of Monensin as an Anti-microbial Agent.
    Rajendran V; Ilamathi HS; Dutt S; Lakshminarayana TS; Ghosh PC
    Curr Top Med Chem; 2018; 18(22):1976-1986. PubMed ID: 30499391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
    Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.